STAT

JUNE 29, 2023

In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. A nurse told him he had only six months to live. He was prescribed a drug cocktail, a combination of interferon and ribavirin, that proved ineffective and gave him severe side effects. recalled.

Drug Pricing 246

Drug Pricing 246

STAT

DECEMBER 13, 2024

billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2

Pharmaceutical Companies 254

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 254

STAT

JUNE 25, 2024

The justices threw out a lower court ruling that revived a lawsuit brought by the military personnel and civilians who said they were harmed between 2005 and 2011 in the Iraq war. The justices asked the lower court to reconsider the case.

273

273

ALiEM - Pharm Pearls

NOVEMBER 22, 2023

The poison Dart frog’s batrachotoxin modulates Nav1.8. 2004;577(1-2):245-248. PMID: 15527793 Darst, Catherine R.; Menéndez-Guerrero, Pablo A.; Coloma, Luis A.; Cannatella, David C.

284

284

Express Pharma

JANUARY 14, 2025

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. People are increasingly leaning towards prevention and preventive care rather than relying solely on therapeutic medications. However, the COVID-19 pandemic served as a significant turning point, increasing awareness about health and wellness.

Diabetes 105

Diabetes Compounding 105

pharmaphorum

AUGUST 12, 2020

Author and journalist John-Manuel Andriote has spent much of his career writing about the impact of HIV/AIDS – a job that became much more personal when he himself was diagnosed in 2005. Then in 2005, three weeks after his 47th birthday, an annual physical checkup changed John’s life forever. “I I had no warning.

128

128

pharmaphorum

JULY 6, 2021

The new figures – from the BioIndustry Association and Clarivate – were dominated by more than £1 billion in venture capital funding for UK biotech and life sciences companies, headlined by DNA sequencing company Oxford Nanopore’s £195 million raise in May that was just shy of the £205 million record set by Immunocore in 2005.

Documentation 141

Documentation Vaccines 141

Pharma Pathway

DECEMBER 28, 2022

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

85

85

Pharma Pathway

JANUARY 7, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

86

86

Pharma Pathway

JANUARY 1, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

85

85

Pharma Pathway

FEBRUARY 4, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. .- Walk-In Interviews for Production/ Quality Control On 5th Feb’ 2023 Job Description Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

Hospitals 84

Hospitals 84

Pharma Pathway

FEBRUARY 26, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

84

84

Pharma Pathway

FEBRUARY 1, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

81

81

PioneerRx

AUGUST 17, 2022

The journey to discovering her niche began in 2005 when her brother, a pharmacist, chose to pursue a career… For Stacy Welling, business has always been personal.

52

52

PioneerRx

AUGUST 17, 2022

The journey to discovering her niche began in 2005 when her brother, a pharmacist, chose to pursue a career… For Stacy Welling, business has always been personal.

52

52

Pharma Pathway

MARCH 2, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

90

90

Pharmacy Times

AUGUST 22, 2023

Zydus Pharmaceuticals (USA) Inc, has come a long way since its first commercial launch in August 2005.

49

49

Pharma Pathway

FEBRUARY 11, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

84

84

Pharma Pathway

MARCH 13, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

80

80

pharmaphorum

NOVEMBER 1, 2021

It is the first oncolytic virus therapy to be launched anywhere in the world for brain cancer, and only the third oncolytic virus therapy to be made available to patients worldwide, after Shanghai Sunway Biotech’s Oncorine for nasopharyngeal carcinoma in 2005 and Amgen’s Imlygic (talimogene laherparepvec) for melanoma 10 years later.

Chemotherapy 122

Chemotherapy Hospitals 122

Pharma Pathway

MARCH 4, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

80

80

Pharma Pathway

MARCH 2, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Ranked amongst the top 10 pharma companies with a strength of 20000 employees, operating in 140+ countries.

81

81

RX Note

MARCH 28, 2023

FAST HUGS BID In 2005, Jean-Louis Vincent introduced the "FAST HUG" mnemonic as a means of identifying and checking some of the key aspects in the general care of all critically ill patients.

52

52

European Pharmaceutical Review

MARCH 15, 2023

Tomáš Pluskal from IOCB Prague has coordinated the project almost since its inception in 2005. A worldwide community of researchers was formed and the software continued to expand its functions. The greatest strength of the MZmine project is the international community of experts that has formed around the project.”

Compounding 139

Compounding 139

ALiEM - Pharm Pearls

MARCH 7, 2024

Ann Emer Med , 2005 [7] Prospective, blinded, observational study performed in the pediatric ED, 3 month period N=44, < 2 years of age Created a bladder urinary index by multiplying the AP and transverse bladder diameters. 2005 Jan;115(1):108-11. The index achieved 100% sensitivity and 97% specificity. Chen et al., Wong et al.,

Labelling 177

Labelling Communication 177

RX Note

JUNE 11, 2023

External Links Medscape - The First 5 Years, 2005 The most popular iPhone medical app, Medscape, is now on Android, 2011 Mobile Application Mobile application for Medscape was released in 2009 and 2011 for iOS and Android system respectively. Do not forget to download the database for offline usage.

52

52

European Pharmaceutical Review

OCTOBER 10, 2022

The FDA initially approved Boostrix in 2005 as a vaccine to protect against Tdap in patients from 10 years old to 18. The endorsement therefore demonstrates significant progress in the industry’s ability to combat the disease in the younger population.

Vaccines 105

Vaccines 105

pharmaphorum

JANUARY 28, 2021

In two phase 3 trials – CALGB 100104 and IFM 2005-02 – Revlimid given as a daily oral dose after a stem cell transplant was able to extend the time patients survived without disease progression compared to placebo. The drug has been approved for this use by the Scottish Medicines Consortium (SMC) since last September.

98

98

National Association of Boards of Pharmacy

OCTOBER 18, 2023

This number has decreased significantly over time; the peak being 2005 with 9.5% The use of narcotics, other than heroin, increased only slightly from 2021, from 1.0% of 12th graders reporting use in the last year. of 12th graders reporting the use of narcotics other than heroin.

Controlled Substances 111

Controlled Substances 111

pharmaphorum

OCTOBER 7, 2022

Starting with the primary care era of 1997-2005, when key launches were primary care blockbusters, such as Losec, Diovan, and Lipitor, IQVIA took five key therapy classes from that era that consistently appeared in the top 10 therapy area by sales for the time period of the era.

95

95

LifeProNow

MARCH 10, 2023

Since 2005, AstraZeneca has achieved an almost six-fold improvement in the proportion of its pipeline molecules that have advanced from preclinical investigation to completion of Phase III clinical trials – from 4% to 23%.

Compounding 100

Compounding 100

LifeProNow

MARCH 12, 2023

Since 2005, AstraZeneca has achieved an almost six-fold improvement in the proportion of its pipeline molecules that have advanced from preclinical investigation to completion of Phase III clinical trials – from 4% to 23%.

Compounding 100

Compounding 100

Pharma Pathway

JANUARY 5, 2023

Our bioequivalence centre was established in 2005 and is responsible for conducting studies for filing product registrations with various regulatory authorities. Macleods Pharmaceuticals, Indian’s fastest growing company was established in 1986.

52

52

European Pharmaceutical Review

OCTOBER 2, 2023

Through [their] discoveries, Karikó and Weissman opened up opportunity for the pharmaceutical industry to advance mRNA technology” These data were published in 2005, fifteen years before the COVID-19 pandemic, of which mRNA vaccines were instrumental to controlling.

Vaccines 111

Vaccines Immunity Immunization 111

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2023

Since I entered the life sciences industry in 2005, I’ve respected HP&M and admired their expertise and elite standing,” said Grizzel. “I Ellison, HP&M’s Managing Director. I’m incredibly excited by the opportunity to work for HP&M and its amazing group of professionals.

59

59

RX Note

FEBRUARY 26, 2023

Since its introduction in 2005, it has underwent numerous editions with the latest being the fifth edition (2020). Introduction Drugs and Drugs is created as a practical guide to the safe use of common drugs in adults. The 130 plus individual chapters are authored by members of the Department of Medicine - University of Alberta.

40

40

pharmaphorum

JANUARY 21, 2021

Aurora was founded in 2005 by Claire Eldridge and Neil Crump and has recently launched a sister consultancy, Atlas. This supports clients to connect with patients and advance products and services through strategy, co-design and organisational change services.

Communication 52

Communication 52